Genertec Universal Medical Group Co Ltd (2666.HK) stock: key figures, P/E, revenue and dividend
Health Care · China · ISIN HK0000255361
Genertec Universal Medical Group Co Ltd financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 13.66 bn CNY | 14.74 bn CNY |
| Gross profit | 4.59 bn CNY | 5.13 bn CNY |
| EBIT | 3.09 bn CNY | 3.09 bn CNY |
| Net income | 2.10 bn CNY | 2.24 bn CNY |
| Diluted EPS – continuing operations | 1.05 CNY | 1.11 CNY |
Full history since 2012, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Genertec Universal Medical Group Co Ltd
Genertec Universal Medical Group Company Limited, together with its subsidiaries, provides financing, advisory, and medical services in the Mainland China. It operates through two segments, Finance Business and Healthcare Business. The Finance Business segment offers direct finance leasing; sale and leaseback; factoring; operating leases; and advisory services. Its Healthcare Business segment includes medical and healthcare services; hospital operations; import, export, and trading of medical-related goods; equipment life cycle management; medical digitalization services; and intelligent medical health and elder care. The company also provides medical and professional technology, financing, hospital management, medical consulting, sale of medical related goods, medical, software development, and elderly care services. It serves patients, hospitals, medical equipment suppliers, and other public institutions. The company was formerly known as Universal Medical Financial & Technical Advisory Services Company Limited and changed its name to Genertec Universal Medical Group Company Limited in July 2018. The company was founded in 1984 and is headquartered in Beijing, China.
More stocks
- Uniphar PLC (UPR.IR)
- Chengdu Haoneng Tech Co Ltd (603809.SS)
- Shanghai Aladdin Biochemical Technology Co. Ltd. A (688179.SS)
- Lamda Development SA (LAMDA.AT)
- MANNKIND CORP (MNKD)
- SkyeChip Berhad (5357.KL)
- SYoung Group Co Ltd (300740.SZ)
- Guangzhou Lingwe Technology Co. Ltd. A (301373.SZ)
- Saratoga Investama Sedaya (SRTG.JK)
- TENNANT CO (TNC)
- Pacific Horizon Investment Trust PLC (PHI.L)
- Hunan Valin Wire & Cable Co Ltd (001208.SZ)
Not investment advice. All data without warranty, price as of 30.10.2026. Details in the risk notice.